Market cap of Heart Test Laboratories Inc [HSCS] reaches 1.68M – now what?

BITF

Heart Test Laboratories Inc [NASDAQ: HSCS] traded at a high on Wednesday, posting a 11.05 gain after which it closed the day’ session at $0.15. The company report on January 18, 2024 at 8:00 AM that HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting.

At the Annual Meeting which was convened, all items of business were passed, with the exception of Proposal 7, which would effect a reduction of the quorum requirements for future shareholder meetings, as the Company had not received sufficient proxies for approval by the time of the Annual Meeting. Accordingly, the meeting was convened and adjourned solely in respect of proposal 7.

The results of the trading session contributed to over 7413456 shares changing hands. Over the past one week, the price volatility of Heart Test Laboratories Inc stands at 11.93% while the volatility over the past one month is 10.84%.

The market cap for HSCS stock reached $1.68 million, with 10.12 million shares outstanding and 9.35 million shares in the current float. Compared to the average trading volume of 10.49M shares, HSCS reached a trading volume of 7413456 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Heart Test Laboratories Inc [HSCS]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HSCS shares is $0.90 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HSCS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

The Average True Range (ATR) for Heart Test Laboratories Inc is set at 0.02, with the Price to Sales ratio for HSCS stock in the period of the last 12 months amounting to 167.93.

How has HSCS stock performed recently?

Heart Test Laboratories Inc [HSCS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 18.61. With this latest performance, HSCS shares dropped by -12.40% in over the last four-week period, additionally sinking by -83.40% over the last 6 months – not to mention a drop of -93.63% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HSCS stock in for the last two-week period is set at 50.69, with the RSI for the last a single of trading hit 58.27, and the three-weeks RSI is set at 46.16 for Heart Test Laboratories Inc [HSCS]. The present Moving Average for the last 50 days of trading for this stock 0.1688, while it was recorded at 0.1366 for the last single week of trading, and 0.5933 for the last 200 days.

Heart Test Laboratories Inc [HSCS]: Deeper insight into the fundamentals

Heart Test Laboratories Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.15 and a Current Ratio set at 0.34.

Earnings analysis for Heart Test Laboratories Inc [HSCS]

With the latest financial reports released by the company, Heart Test Laboratories Inc posted -0.16/share EPS, while the average EPS was predicted by analysts to be reported at -0.16/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HSCS.

Insider trade positions for Heart Test Laboratories Inc [HSCS]

The top three institutional holders of HSCS stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in HSCS stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in HSCS stock with ownership which is approximately 5.8325%.